[1]张文航.曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴 血脂异常的临床疗效[J].医学信息,2019,32(18):144-145148.[doi:10.3969/j.issn.1006-1959.2019.18.049]
　ZHANG Wen-hang.Clinical Efficacy of Trimetazidine Combined with Atorvastatin Calcium in the Treatment of Coronary Heart Disease Angina Pectoris with Dyslipidemia[J].Journal of Medical Information,2019,32(18):144-145148.[doi:10.3969/j.issn.1006-1959.2019.18.049]
点击复制

曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴 血脂异常的临床疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年18期
页码:
144-145148
栏目:
药物与临床
出版日期:
2019-09-15

文章信息/Info

Title:
Clinical Efficacy of Trimetazidine Combined with Atorvastatin Calcium in the Treatment of Coronary Heart Disease Angina Pectoris with Dyslipidemia
文章编号:
1006-1959（2019）18-0144-03
作者:
张文航
遵义医科大学附属医院心内科，贵州 遵义 563000
Author(s):
ZHANG Wen-hang
Department of Cardiology,Affiliated Hospital of Zunyi Medical University,Zunyi 563000,Guizhou,China
关键词:
曲美他嗪; 阿托伐他汀钙; 冠心病心绞痛; 血脂异常
Keywords:
key words：Trimetazidine; Atorvastatin calcium; Coronary heart disease angina pectoris;  Dyslipidemia
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2019.18.049
文献标志码:
A
摘要:
目的 分析曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴血脂异常的临床疗效和安全性。方法 选取我院2018年5月~9月收治的冠心病心绞痛伴血脂异常患者70例，随机分为治疗组和对照组，各35例，对照组患者使用曲美他嗪治疗，治疗组在对照组基础上联合阿托伐他汀钙治疗，检测两组患者血清总胆固醇、甘油三酯、高密度脂蛋白和低密度脂蛋白水平，比较两组治疗总有效率及不良反应情况。结果 治疗组血清总胆固醇、甘油三酯和低密度脂蛋白水平分别为（1.25±0.35）mmol/L、（4.89±0.45）mmol/L、（3.24±0.68）mmol/L，均低于对照组的（2.35±0.48）mmol/L、（6.01±0.51）mmol/L、（4.21±0.59）mmol/L，差异有统计学意义（P＜0.05）；治疗组高密度脂蛋白水平为（1.35±0.23）mmol/L，高于对照组的（0.95±0.18）mmol/L，差异有统计学意义（P＜0.05）；治疗组总有效率为94.29%，高于对照组的74.29%，差异有统计学意义（P＜0.05）；治疗组不良反应发生率为2.85%，低于对照组的31.42%，差异有统计学意义（P＜0.05）。结论 曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴血脂异常患者临床效果更佳，可有效改善患者血脂异常情况，且不良反应少，安全性高。
Abstract:
Abstract：Objective To analyze the clinical efficacy and safety of trimetazidine combined with atorvastatin calcium in the treatment of angina pectoris with dyslipidemia.Methods 70 patients with coronary heart disease angina pectoris and dyslipidemia were enrolled in our hospital from May to September 2018.They were randomly divided into treatment group and control group, 35 cases in each group. The control group was treated with trimetazidine. The treatment group was treated with atorvastatin calcium based on control group. The serum total cholesterol, triglyceride, high-density lipoprotein and low-density lipoprotein levels were measured in the two groups, and the total effective rate and adverse reactions were compared between two groups. Results The serum total cholesterol, triglyceride, and low-density lipoprotein levels in the treatment group were （1.25±0.35）mmol/L,（4.89±0.45）mmol/L,（3.24±0.68）mmol/L,respectively, which were lower than that in the control group（2.35±0.48）mmol/L,（6.01±0.51）mmol/L,（4.21±0.59）mmol/L,the difference was statistically significant(P<0.05). The high-density lipoprotein in the treatment group was（1.35±0.23）mmol/L,which was higher than that in the control group（0.95±0.18）mmol/L,the difference was statistically significant(P<0.05).The total effective rate of the treatment group was 94.29%, which was higher than that in control group 74.29%,the difference was statistically significant (P<0.05). The incidence of adverse reactions in the treatment group was 2.85%, which was lower than that in the control group 31.42%,the difference was statistically significant (P<0.05).Conclusion Trimetazidine combined with atorvastatin calcium is more effective in the treatment of patients with coronary heart disease angina pectoris and dyslipidemia. It can effectively improve the dyslipidemia of patients with less adverse reactions and high safety.

参考文献/References:

[1]陈慧敏,许逸飞.曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴血脂异常的临床研究[J].中国临床药理学杂志,2016,32(11):966-968. [2]陈召正.联用阿托伐他汀钙片和盐酸曲美他嗪治疗冠心病的效果观察[J].当代医药论丛,2015(16):148-149. [3]余萍,厉莎莎,蒋利真.曲美他嗪、阿托伐他汀钙、心理干预联用治疗冠心病心绞痛伴血脂异常的临床研究[J].中国生化药物杂志,2017,37(9):143-145. [4]张冬梅,张军,李恭.盐酸曲美他嗪胶囊联合阿托伐他汀钙片对冠心病患者血小板活化功能和血管内皮功能的影响[J].药物评价研究,2019,42(1):113-116. [5]徐恺.阿托伐他汀钙联合曲美他嗪对冠心病患者血脂及心功能指标的影响[J].北方药学,2018,15(11):151-152. [6]方文仲.阿托伐他汀联合曲美他嗪治疗冠心病心绞痛的临床疗效分析[J].中西医结合心血管病电子杂志,2017,5(32):59,62. [7]伍新诚,马晓聪,卓小媛,等.复方丹参滴丸联合曲美他嗪治疗冠心病心绞痛疗效和安全性Meta分析[J].辽宁中医药大学学报,2017,19(4):72-77. [8]闫锋,侯亚锋,王亮,等.通心络胶囊联合曲美他嗪治疗冠心病心绞痛临床疗效及安全性[J].临床医学研究与实践,2017,2(18):41-42. [9]田思强,华丽.理气活血滴丸联合曲美他嗪治疗冠心病心绞痛的临床研究[J].中西医结合心脑血管病杂志,2018,16(17):2597-2599.

相似文献/References:

[1]郭建华.丹参川芎嗪联合阿托伐他汀钙治疗急性心肌梗死的疗效观察[J].医学信息,2018,31(01):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
　GUO Jian-hua.Effect of Salvia Miltiorrhiza Tetramethylpyrazine Combined with Atorvastatin Calcium in the Treatment of Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(18):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
[2]胡丽君.螺内酯联合曲美他嗪治疗慢性心力衰竭的疗效分析[J].医学信息,2018,31(08):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
　HU Li-jun.Efficacy of Spironolactone Combined with Trimetazidine in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2018,31(18):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
[3]王 毅.阿托伐他汀联合曲美他嗪治疗冠心病的临床效果评价[J].医学信息,2018,31(13):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
　WANG Yi.Clinical Evaluation of Atto Vastatin Combined with Trimetazidine in the Treatment of Coronary Atherosclerotic Heart Disease[J].Journal of Medical Information,2018,31(18):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
[4]何玲玲,程淑芬.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭疗效观察[J].医学信息,2018,31(13):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
　HE Ling-ling,CHENG Shu-fen.Therapeutic Effect of Trimetazidine Combined with Metoprolol Succinate in the Treatment of Coronary Heart Disease with Heart Failure[J].Journal of Medical Information,2018,31(18):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
[5]宫慧超,王 辉,刘迎午.尼可地尔联合曲美他嗪在不稳定心绞痛患者中应用的临床研究[J].医学信息,2019,32(07):148.[doi:10.3969/j.issn.1006-1959.2019.07.045]
　GONG Hui-chao,WANG Hui,LIU Ying-wu.Clinical Study of Nicorandil Combined with Trimetazidine in Patients with Unstable Angina Pectoris[J].Journal of Medical Information,2019,32(18):148.[doi:10.3969/j.issn.1006-1959.2019.07.045]
[6]纪东华.曲美他嗪治疗老年冠心病心力衰竭的疗效及其对患者 炎症因子的影响[J].医学信息,2019,32(13):141.[doi:10.3969/j.issn.1006-1959.2019.13.043]
　JI Dong-hua.Efficacy of Trimetazidine in the Treatment of Elderly Patients with Coronary Heart Disease and Its Effect on Inflammatory Factors[J].Journal of Medical Information,2019,32(18):141.[doi:10.3969/j.issn.1006-1959.2019.13.043]
[7]郝媛媛.富马酸比索洛尔联合曲美他嗪治疗急性冠心病心力衰竭的疗效[J].医学信息,2020,33(02):147.[doi:10.3969/j.issn.1006-1959.2020.02.044]
　HAO Yuan-yuan.Effect of Bisoprolol Fumarate Combined with Trimetazidine in the Treatment of Heart Failure in Patients with Acute Coronary Heart Disease[J].Journal of Medical Information,2020,33(18):147.[doi:10.3969/j.issn.1006-1959.2020.02.044]
[8]栾学冰.依折麦布联合阿托伐他汀钙治疗冠心病的效果[J].医学信息,2020,33(08):169.[doi:10.3969/j.issn.1006-1959.2020.08.057]
　LUAN Xue-bing.Effect of Ezetimibe Combined with Atorvastatin Calcium on Coronary Heart Disease[J].Journal of Medical Information,2020,33(18):169.[doi:10.3969/j.issn.1006-1959.2020.08.057]
[9]刘梓良,曹德斌.氯吡格雷联合阿托伐他汀钙治疗缺血性脑卒中患者的疗效及对神经功能的影响[J].医学信息,2021,34(17):111.[doi:10.3969/j.issn.1006-1959.2021.17.028]
　LIU Zi-liang,CAO De-bin.Efficacy of Clopidogrel Combined with Atorvastatin Calcium in the Treatment of Patients with Ischemic Stroke and its Effect on Neurological Function[J].Journal of Medical Information,2021,34(18):111.[doi:10.3969/j.issn.1006-1959.2021.17.028]
[10]管海兵,葛 胜,沈 斌.阿托伐他汀钙联合依达拉奉对急性脑梗死患者hs-CRP和同型半胱氨酸水平的影响[J].医学信息,2021,34(19):110.[doi:10.3969/j.issn.1006-1959.2021.19.028]
　GUAN Hai-bing,GE Sheng,SHEN Bin.The Effect of Atorvastatin Calcium Combined with Edaravone on hs-CRP andHomocysteine Levels in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2021,34(18):110.[doi:10.3969/j.issn.1006-1959.2021.19.028]
[11]岳卫东.曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴血脂异常的临床研究[J].医学信息,2018,31(21):141.[doi:10.3969/j.issn.1006-1959.2018.21.040]
　YUE Wei-dong.Clinical Study of Trimetazidine Combined with Atorvastatin Calcium in the Treatment of Coronary Heart Disease Angina Pectoris with Dyslipidemia[J].Journal of Medical Information,2018,31(18):141.[doi:10.3969/j.issn.1006-1959.2018.21.040]

更新日期/Last Update: 2019-09-15